Nano Labs Ltd
NA · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.41 | 0.00 | -0.01 |
| FCF Yield | -2.36% | -4.80% | -5.41% | -6.55% |
| EV / EBITDA | -86.98 | -23.87 | -69.01 | -58.26 |
| Quality | ||||
| ROIC | -1.46% | -2.28% | -4.61% | -8.87% |
| Gross Margin | -129.28% | -129.28% | 141.81% | 141.81% |
| Cash Conversion Ratio | 7.20 | 7.20 | 1.12 | 1.12 |
| Growth | ||||
| Revenue 3-Year CAGR | -66.73% | -65.94% | -65.44% | -63.93% |
| Free Cash Flow Growth | 0.00% | 22.16% | 0.00% | 39.82% |
| Safety | ||||
| Net Debt / EBITDA | -19.89 | 9.08 | -14.80 | -13.42 |
| Interest Coverage | -6.85 | -6.85 | -6.14 | -6.14 |
| Efficiency | ||||
| Inventory Turnover | 0.26 | 0.26 | 0.11 | 0.33 |
| Cash Conversion Cycle | 130.89 | 130.89 | 902.93 | -37.45 |